Phase 3 study shows HER2 therapy clinically meaningful for metastatic breast cancer patients
Phase 3 study shows HER2 therapy clinically meaningful for metastatic breast cancer patients
High-dose ifosfamide standard of care for recurrent and primary refractory ewing sarcoma
Lenalidomide, bortezomib, and dexamethasone ASCT to progress for NDMM: Phase 3 DETERMINATION trial
Single-agent PD-1 blockade as curative-intent treatment in mismatch repair-deficient locally advanced rectal cancer
Ibrutinib improves PFS by 50% for older patients with newly diagnosed mantle cell lymphoma
Outcomes of clinico-radiologically advanced cancer (cT4b) of buccal mucosa: A retrospective analysis of 104 patients
COMy 2022: Multiple myeloma roundup
Giving abatacept after checkpoint inhibitors can improve immunotherapy responses in melanoma
Long-term outcomes with sotorasib in pretreated KRASp.G12C-mutated NSCLC: 2-year analysis of CodeBreaK100
Nivolumab plus platinum-doublet chemo vs chemo as neoadjuvant treatment for resectable NSCLC
War in Ukraine: Impacts on the Polish cancer care system and vaccination challenges
War in Ukraine: Current and future impacts on the Romanian cancer care system